REHABCARE GROUP INC
8-K/A, 1998-11-10
HOSPITALS
Previous: SANDERSON FARMS INC, 4, 1998-11-10
Next: JANUS CAPITAL CORP, SC 13G/A, 1998-11-10





<PAGE> 1
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549


                       ----------------------------------

                                  AMENDMENT NO. 1
                                        ON
                                    FORM 8-K/A

                                 CURRENT REPORT

                       PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934


        Date of Report (Date of earliest event reported): September 9, 1998



                              REHABCARE GROUP, INC.
             (Exact name of registrant as specified in its charter)


Delaware                         0-19294                           51-0265872
(State or other              (Commission File                   (I.R.S. Employer
jurisdiction of                  Number)                         Identification
organization)                                                        Number)



        7733 Forsyth Boulevard
              17th Floor
          St. Louis, Missouri                                    63105
(Address of principal executive offices)                       (Zip Code)



       Registrant's telephone number, including area code: (314) 863-7422


- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------


<PAGE> 2



Item 7.   Financial Statements, Pro Forma Financial Information and Exhibits

     Historical  and Pro Forma  Financial  Statements - The following sets forth
the historical financial  statements of Therapeutic  Systems,  Ltd., an Illinois
corporation  ("TSL"),  and the  unaudited  pro forma  financial  information  of
RehabCare Group, Inc.  ("RehabCare"),  showing the effect of the consummation of
the  acquisition  by RehabCare of 100% of the issued and  outstanding  shares of
TSL. The  consummation  of the  acquisition and details with regard thereto were
reported by RehabCare in its Current Report on Form 8-K dated September 9, 1998,
but  the  audited  financial  statements  of TSL  and the  unaudited  pro  forma
financial information were not available at such time.

(a)  Historical  Financial  Statements  of  Business  Acquired  - The  following
     historical financial statements of TSL are filed herewith:

     Report of Independent Auditors
     Balance Sheet, December 31, 1997
     Statement of Income, Year Ended December 31, 1997
     Statement of Cash Flows,  Year Ended December 31, 1997
     Notes to Financial  Statements  
     Condensed Balance Sheet, June 30, 1998 (Unaudited)  
     Condensed Statement of Earnings, Six Months Ended June 30, 1998 (Unaudited)
     Condensed Statement of Cash Flows, Six Months Ended June 30, 1998
          (Unaudited)
     Notes to Condensed Financial Statements (Unaudited)

(b)  Pro  Forma  Financial  Information  -  The  following  pro  forma  combined
     financial statements of RehabCare showing the effect of the acquisition are
     filed herewith:

     Pro Forma Condensed Combined Balance Sheet as of June 30, 1998 (Unaudited)
     Pro Forma Condensed Combined Statement of Earnings for the Year Ended
          December 31, 1997 (Unaudited)
     Pro Forma Condensed Combined Statement of Earnings for the Six Months Ended
          June 30, 1998 (Unaudited)
     Notes to  Unaudited  Pro  Forma  Condensed  Combined  Financial  Statements
          (Unaudited)

(c) Exhibits -The following exhibits are filed herewith:

     23.1     Consent of Mowery & Schoenfeld LLC.




<PAGE> 3

REPORT OF INDEPENDENT AUDITORS



TO THE BOARD OF DIRECTORS OF

         THERAPEUTIC SYSTEMS, LTD.

We have audited the accompanying balance sheet of THERAPEUTIC SYSTEMS,  LTD. (an
Illinois  corporation),  as of December 31, 1997 and the related  statements  of
income and cash flows for the year then ended.  These  financial  statements are
the responsibility of the Company's management. Our responsibility is to express
an opinion on these financial statements based on our audit.

We  conducted  our audit in  accordance  with the  generally  accepted  auditing
standards.  Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe that our audit provides a reasonable basis for our opinion.

In our opinion,  the financial  statements  referred to above present fairly, in
all material respects, the financial position of THERAPEUTIC SYSTEMS, LTD. as of
December 31, 1997,  and the results of its operations and its cash flows for the
year then ended in conformity with generally accepted accounting principles.



                                                         Mowery & Schoenfeld LLC


May 15, 1998


<PAGE> 4

<TABLE>


                            THERAPEUTIC SYSTEMS, LTD.

                                  BALANCE SHEET

                                DECEMBER 31, 1997

- --------------------------------------------------------------------------------------------------------------------------
<CAPTION>

                                     ASSETS

<S>
CURRENT ASSETS                                                            <C>               <C>               <C>
   Cash                                                                                                       $   119,697
   Accounts receivable
      Trade                                                                                 $ 7,057,348
      Allowance for doubtful accounts                                                          (230,000)        6,827,348
                                                                                            -----------
   Prepaid expenses                                                                                                 4,443
                                                                                                              -----------

      Total assets                                                                                            $ 6,951,488
                                                                                                              ===========


                      LIABILITIES AND SHAREHOLDER'S EQUITY


CURRENT LIABILITIES
   Accrued payroll and payroll taxes                                                                          $   580,584
   Accrued vacation                                                                                               227,000
   Accrued replacement taxes  (Note 3)                                                                             83,000
   Deferred replacement taxes  (Note 3)                                                                            91,000
                                                                                                              -----------
      Total current liabilities                                                                                   981,584
                                                                                                              -----------
SHAREHOLDER'S EQUITY
   Common stock - no par value, 10,000 shares authorized,
      1,000 shares issued and outstanding                                                                           1,000
   Retained earnings, beginning of the year                                                 $ 5,839,309
   Net income                                                             $ 6,296,714
   Shareholder distributions                                               (6,167,119)          129,595         5,968,904
                                                                          -----------       -----------       -----------
      Total shareholder's equity                                                                                5,969,904
                                                                                                              -----------

      Total liabilities and shareholder's equity                                                              $ 6,951,488
                                                                                                              ===========








                 See accompanying notes to financial statements.
</TABLE>


<PAGE> 5
<TABLE>


                            THERAPEUTIC SYSTEMS, LTD.

                               STATEMENT OF INCOME

                      FOR THE YEAR ENDED DECEMBER 31, 1997

- --------------------------------------------------------------------------------------------------------------------------

<CAPTION>
<S>                                                                                         <C>               <C>
REVENUES                                                                                                      $13,866,613

OPERATING EXPENSES
   Wages                                                                                    $ 6,599,283
   Payroll taxes                                                                                529,292

   Dues and subscriptions                                                                         3,911
   Employee health                                                                                  616
   Licenses                                                                                       1,642
   Continuing education                                                                           7,280
   Health insurance                                                                             148,141
   Dental insurance                                                                               4,901

   Professional liability insurance                                                              20,991
   Workers compensation insurance                                                                27,107
   Advertising                                                                                   17,371
   Client relations                                                                               4,851

   Office supplies                                                                               12,263
   Postage and delivery                                                                           7,241
   Professional fees                                                                              6,829
   Bad debt expense                                                                              50,000

   Rent                                                                                          29,520
   Therapy materials                                                                              9,307
   Travel and entertainment                                                                       1,398

   Telephone                                                                                     15,514
   Gas and electric                                                                               3,221
   Miscellaneous                                                                                  1,434         7,502,113
                                                                                            -----------       -----------

   Income from operations                                                                                       6,364,500

OTHER INCOME
   Interest income                                                                                                 25,214
                                                                                                              -----------

         Income before taxes                                                                                    6,389,714

PROVISION FOR ILLINOIS REPLACEMENT TAXES ( NOTE 3 )                                                                93,000
                                                                                                              -----------

      Net income                                                                                              $ 6,296,714
                                                                                                              ===========



                 See accompanying notes to financial statements.

</TABLE>


<PAGE> 6
<TABLE>

                            THERAPEUTIC SYSTEMS, LTD.

                             STATEMENT OF CASH FLOWS

                      FOR THE YEAR ENDED DECEMBER 31, 1997

- --------------------------------------------------------------------------------------------------------------------------
<CAPTION>
<S>                                                                                                           <C>
CASH FLOWS FROM OPERATING ACTIVITIES
   Net income                                                                                                 $ 6,296,714
   Adjustments to reconcile net income to net cash
      provided by operating activities;
            Deferred replacement taxes                                                                             10,000
            Bad debts expense                                                                                      50,000
            Effect of changes in operating assets and liabilities;
               Accounts receivable                                                                               (774,640)
               Prepaid expenses                                                                                    29,172
               Accrued payroll and payroll taxes                                                                    9,418
               Accrued vacation                                                                                    36,000
               Accrued replacement taxes                                                                          (12,000)
                                                                                                              -----------
                    Net cash provided by operating activities                                                   5,644,664
                                                                                                              -----------


CASH FLOWS FROM INVESTING ACTIVITIES                                                                                    -
                                                                                                              -----------


CASH FLOWS FROM FINANCING ACTIVITIES
   Dividends paid                                                                                              (6,167,119)
                                                                                                              -----------
      Net cash used in financing activities                                                                    (6,167,119)
                                                                                                              -----------


NET DECREASE IN CASH                                                                                             (522,455)
Cash, beginning of year                                                                                           642,152
                                                                                                              -----------

Cash, end of year                                                                                             $   119,697
                                                                                                              ===========



SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid during the year for replacement taxes                                                               $    95,000
                                                                                                              ===========










                 See accompanying notes to financial statements.
</TABLE>

<PAGE> 7

                            THERAPEUTIC SYSTEMS, LTD.

                          Notes to Financial Statements



NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


          Nature of Business
          ------------------
          Therapeutic  Systems,  Ltd. ("the Company") is an Illinois corporation
          operating within Chicago,  Illinois and the surrounding  suburbs.  The
          Company  contracts  primarily  with skilled  nursing or long-term care
          facilities  and school  districts to provide  comprehensive  physical,
          occupational and speech therapy.

          Basis of Presentation and Revenue Recognition
          ---------------------------------------------
          The financial statements are presented on the accrual basis.  Revenues
          are recognized as services are performed  based on contracted  billing
          rates.  Expenses are recorded as incurred and as services are provided
          by therapists.

          Property and Equipment
          ----------------------
          Property and equipment are recorded at cost and are depreciated  using
          straight-line  and  accelerated  methods over estimated  useful lives.
          Expenditures  for major repairs and betterments that extend the useful
          lives of property and  equipment  are  capitalized.  Expenditures  for
          normal  maintenance  and repairs  are charged to expense as  incurred.
          Property and  equipment  are written off the books when they are fully
          depreciated.

          Use of Estimates in Preparing Financial Statements
          --------------------------------------------------
          The  preparation of financial  statements in conformity with generally
          accepted  accounting  principles requires management to make estimates
          and assumptions  that affect certain  reported amounts and disclosures
          at the financial  statement  date.  Accordingly,  actual amounts could
          differ.


NOTE 2 - LEASE COMMITMENTS

The Company leases office  facilities  under an operating  lease  agreement that
expires  December 31, 1997. The lease agreement  contains an option to renew the
lease for four  additional  one year  periods.  The Company has exercised one of
four  one  year  renewal  options  contained  in the  original  lease  agreement
extending  the lease  through  December 31, 1998 with  monthly rent  payments of
$2,546. 

Rent expense approximated $30,000 for the year ended December 31, 1997.


<PAGE> 8

NOTE 3 - INCOME TAXES

The Company has elected to be treated as an S Corporation  under Section 1361 of
the Internal  Revenue Code.  Accordingly,  there is no provision for federal and
state  income  taxes  since  such  taxes  are the  liability  of the  individual
shareholder.  Instead,  the Company is subject to an Illinois replacement tax of
1.5%. The provision for  replacement  taxes for the year ended December 31, 1997
is presented below:



Replacement taxes currently payable                       $   83,000
Deferred replacement taxes                                    10,000
                                                    ----------------
                                                          $   93,000
                                                    ================

Gross deferred replacement tax assets                     $  (15,000)
Gross deferred replacement tax liabilities                   106,000
                                                    ----------------
   Net deferred tax liability - current                   $   91,000
                                                    ================

The Company  files its  federal and state  income tax returns on the cash basis.
Accordingly,  deferred replacement tax assets and liabilities are recorded based
on the  expected  future  tax  consequences  due to the  reversal  of  temporary
differences  between financial  statement  carrying amounts and the tax basis of
primarily accounts receivable and certain accruals which currently exist.




<PAGE> 9
<TABLE>
                            THERAPEUTIC SYSTEMS, LTD.
                             CONDENSED BALANCE SHEET
                                  June 30, 1998
                                  (Unaudited)
                          (dollar amounts in thousands)
<CAPTION>

                                                                                 
                                                                          
                          Assets:
<S>                                                            <C>              
Current assets:
         Cash and cash equivalents                             $       1,611           
         Accounts receivable, net of allowance for
           doubtful accounts                                           6,786             
         Prepaid expenses and other current assets                        20        
                                                                ------------      
         Total current assets                                          8,417       
                                                                ------------         
                                                               $       8,417    
                                                                ============     

            Liabilities and Stockholders' Equity:

Current liabilities:
         Accounts payable                                                107           
         Accrued salaries and wages                                      857                   
                                                                ------------      
         Total current liabilities                                       964        
                                                                ------------      

Stockholder's equity:
         Common stock                                                      1            
         Additional paid-in capital                                      --          
         Retained earnings                                             7,452          
                                                                ------------      
         Total stockholder's equity                                    7,453        
                                                                ------------      
                                                               $       8,417    
                                                                ============     

                            See accompanying notes.
</TABLE>



<PAGE> 10


<TABLE>


                            THERAPEUTIC SYSTEMS, LTD.
                         CONDENSED STATEMENT OF EARNINGS
                         Six months ended June 30, 1998
                                  (Unaudited)
                         (dollar amounts in thousands)

<CAPTION>
                                                                    
<S>                                                         <C>              
Operating Revenues:                                         $        6,571   

Costs and expenses:
         Operating expenses                                          3,393  
         General and administrative                                    127     
         Depreciation and amortization                                 --       
                                                             -------------     
         Total costs and expenses                                    3,520     
                                                             -------------     

         Operating earnings                                          3,051      

Income taxes                                                           --     
                                                             -------------     

         Net earnings                                       $        3,051   
                                                             =============     



                            See accompanying notes.

</TABLE>





<PAGE> 11

<TABLE>

                            THERAPEUTIC SYSTEMS, LTD.
                        CONDENSED STATEMENT OF CASH FLOWS
                         Six months ended June 30, 1998
                                  (Unaudited)
                         (dollar amounts in thousands)

<CAPTION>
<S>                                                                                           <C>
Operating activities
   Net earnings                                                                               $    3,051
   Adjustments to reconcile net earnings to net cash
      provided by operating activities;
            Changes in operating assets and liabilities;
               Accounts receivable                                                                    41
               Prepaid expenses and other assets                                                     (15)
               Accounts payable and accrued expenses                                                 (17)
                                                                                              ----------
Net cash provided by operating activities                                                          3,060
                                                                                              ----------

Financing activities
Dividends paid                                                                                    (1,568)
                                                                                              ----------
Net cash used in financing activities                                                             (1,568)
                                                                                              ----------

Net increase in cash                                                                               1,492
Cash at beginning of period                                                                          119
                                                                                              ----------

Cash at end of period                                                                         $    1,611
                                                                                              ==========




                             See accompanying notes.
</TABLE>



<PAGE> 12

                           THERAPEUTIC SYSTEMS, LTD.

                    Notes to Condensed Financial Statements
                                  (Unaudited)

1.   Basis of Presentation

     The condensed  balance sheet as of June 30, 1998, and the related condensed
statement of earnings for the six months ended June 30, 1998 and cash flows for
the six months ended June 30, 1998, are unaudited. In the opinion of management,
all adjustments  necessary for a fair presentation of such financial  statements
have been included.  Such adjustments  consisted only of normal recurring items.
The  results  of  operations  for the six  months  ended  June 30,  1998 are not
necessarily  indicative  of the results to be expected for the  respective  full
years.

     The  condensed  financial  statements  do not include all  information  and
footnotes necessary for a complete  presentation of financial position,  results
of operations and cash flows in conformity  with generally  accepted  accounting
principles.  Reference  is  made to the  audited  financial  statements  and the
related notes of Therapeutic  Systems,  Ltd.  ("TSL")  included in this Form 8-K
which provide  additional  disclosures  and a further  description of accounting
policies.

2.   Acquisition

     On September 8, 1998, 100% of the common stock of TSL was sold to RehabCare
Group, Inc.


<PAGE> 13

Pro Forma Financial Data

The unaudited pro forma  condensed  combined  balance sheet as of June 30, 1998,
and the pro forma condensed  combined  statements of earnings for the six months
ended June 30, 1998,  and for the year ended  December 31, 1997,  give effect to
the acquisition  based on the historical  consolidated  financial  statements of
RehabCare and the historical  financial statements of TSL, under the assumptions
and adjustments set forth below.

The pro forma condensed combined  financial  statements have been prepared based
upon the respective company's historical financial  statements.  These pro forma
condensed combined financial statements,  which include results of operations as
if the acquisition had been effected on the first day of the periods  presented,
and had been accounted for under the purchase  method of accounting,  may not be
indicative of the results that would be recognized if the  acquisition  had been
in  effect on the  dates  indicated  or which  may be  obtained  in the  future,
including the year ended  December 31, 1998.  The pro forma  condensed  combined
financial   statements  should  be  read  in  conjunction  with  the  historical
consolidated financial statements and notes thereto of RehabCare and TSL.


<PAGE> 14

<TABLE>

                              REHABCARE GROUP, INC.
              UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET
                                  June 30, 1998
                          (dollar amounts in thousands)
<CAPTION>

                                                                                 Therapeutic      Pro Forma         Pro Forma
                                                                    RehabCare      Systems       Adjustments         Combined

                          Assets:
<S>                                                            <C>              <C>           <C>                <C>
Current assets:
         Cash and cash equivalents                             $       4,406    $     1,611   $      (1,753)(1)  $      4,264
         Marketable securities, available-for-sale                     4,314            --                              4,314
         Accounts receivable, net of allowance for
           doubtful accounts                                          24,872          6,786          (4,400)(6)        27,258
         Deferred tax assets                                           1,633            --                              1,633
         Prepaid expenses and other current assets                       963             20                               983
                                                                ------------      ---------     -----------       -----------
         Total current assets                                         36,188          8,417          (6,153)           38,452
                                                                ------------      ---------     -----------       -----------
Marketable securities available-for-sale,
         noncurrent                                                    1,217            --                              1,217
                                                                ------------      ---------     -----------       -----------
Equipment and leasehold improvements, net                              3,302            --                              3,302
                                                                ------------      ---------     -----------       -----------
Other assets:
         Excess of cost over net assets acquired, net                 54,605            --    $       7,300 (3)        61,905
         Deferred contract costs, net                                  1,071            --                              1,071
         Pre-opening costs, net                                        3,164            --                              3,164
         Other                                                         1,672            --                              1,672
                                                                ------------      ---------     -----------       -----------
         Total other assets                                           60,512            --            7,300            67,812
                                                                ------------      ---------     -----------       -----------
                                                               $     101,219    $     8,417   $       1,147      $    110,783
                                                                ============      =========     ===========       ===========

            Liabilities and Stockholders' Equity:

Current liabilities:
         Current portion of long-term debt                     $       4,660    $       --    $         --       $      4,660
         Accounts payable                                              1,851            107             --              1,958
         Accrued salaries and wages                                   12,793            857                            13,650
         Accrued expenses                                              4,069            --              300 (1)         4,369
                                                                ------------      ---------     -----------       -----------
         Total current liabilities                                    23,373            964             300            24,637
                                                                ------------      ---------     -----------       -----------
Deferred tax liabilities                                                 257            --                                257
                                                                ------------      ---------     -----------       -----------
Deferred compensation                                                  1,715            --                              1,715
                                                                ------------      ---------     -----------       -----------
Long-term debt, less current portion                                  26,351            --            6,400 (1)        32,751
                                                                ------------      ---------     -----------       -----------

Stockholders' equity:
         Preferred stock                                                 --             --                                --
         Common stock                                                     73              1              (1)(2)            73
         Additional paid-in capital                                   25,748            --            1,900 (1)        27,648
         Retained earnings                                            40,911          7,452          (7,452)(2)        40,911
         Less common stock held in treasury at cost,
           1,166,234 shares                                          (17,975)           --                            (17,975)
         Accumulated other comprehensive earnings -
           unrealized gain on marketable securities,
           net of tax                                                    766            --                                766
                                                                ------------      ---------     -----------       -----------
         Total stockholders' equity                                   49,523          7,453          (5,553)           51,423
                                                                ------------      ---------     -----------       -----------
                                                               $     101,219    $     8,417   $       1,147      $    110,783
                                                                ============      =========     ===========       ===========

See accompanying notes to unaudited pro forma condensed combined financial statements.
</TABLE>


<PAGE> 15

<TABLE>

                              REHABCARE GROUP, INC.
          UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF EARNINGS
                          Year ended December 31, 1997
              (dollar amounts in thousands, except per share data)

<CAPTION>
                                                                               Therapeutic      Pro Forma         Pro Forma
                                                                  RehabCare      Systems       Adjustments        Combined


<S>                                                         <C>              <C>            <C>               <C>
Operating Revenues:                                         $      160,780   $     13,866   $     (6,366)(6)  $    168,280

Costs and expenses:
         Operating expenses                                        110,726          7,247         (3,327)(6)       114,851
                                                                                                     205 (7)              
         General and administrative                                 27,294            254             88 (7)        27,636
         Depreciation and amortization                               3,780            --             183 (3)         3,963
                                                             -------------     ----------    -----------      ------------
         Total costs and expenses                                  141,800          7,501         (2,851)          146,450
                                                             -------------     ----------    -----------      ------------

         Operating earnings                                         18,980          6,365         (3,515)           21,830

Interest income                                                        186             25                              211
Interest expense                                                    (2,759)           --            (480)(4)        (3,239)
Gain on sale of marketable securities                                1,448            --                             1,448
Other income, net                                                       27            --                                27
                                                             -------------     ----------    -----------      ------------

         Earnings before income taxes                               17,882          6,390         (3,995)           20,277

Income taxes                                                         7,267             93            751             8,111 (5)
                                                             -------------     ----------    -----------      ------------

         Net earnings                                       $       10,615   $      6,297   $     (4,746)     $     12,166
                                                             =============     ==========    ===========      ============


Net earnings per common share:
         Basic                                              $         1.77                                    $       2.03
                                                             =============                                    ============
         Diluted                                            $         1.47                                    $       1.65
                                                             =============                                    ============

  See accompanying notes to unaudited pro forma condensed combined financial statements.


</TABLE>




<PAGE> 16

<TABLE>


                              REHABCARE GROUP, INC.
          UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF EARNINGS
                         Six  months  ended  June 30,  1998  
              (dollar amounts in thousands, except per share data)

<CAPTION>
                                                                                Therapeutic     Pro Forma        Pro Forma
                                                                   RehabCare      Systems      Adjustments        Combined

<S>                                                         <C>              <C>             <C>              <C>
Operating Revenues:                                         $       86,531   $      6,571    $   (3,113)(6)   $     89,989

Costs and expenses:
         Operating expenses                                         58,621          3,393        (1,607)(6)         60,509
                                                                                                    102 (7)               
         General and administrative                                 15,131            127            44 (7)         15,302
         Depreciation and amortization                               2,021            --             91 (3)          2,112
                                                             -------------     ----------    -----------      ------------
         Total costs and expenses                                   75,773          3,520        (1,370)            77,923
                                                             -------------     ----------    -----------      ------------

         Operating earnings                                         10,758          3,051        (1,743)(7)         12,066

Interest income                                                        124             --                              124
Interest expense                                                    (1,352)            --          (229)(4)         (1,581)
Gain on sale of marketable securities                                   94             --                               94
                                                             -------------     ----------    -----------      ------------

         Earnings before income taxes                                9,624          3,051        (1,972)            10,703

Income taxes                                                         3,905            --            376              4,281 (5)
                                                             -------------     ----------    -----------      ------------

         Net earnings                                       $        5,719   $      3,051   $    (2,348)      $      6,422
                                                             =============     ==========    ===========      ============


Net earnings per common share:
         Basic                                              $         0.96                                     $      1.07
                                                             =============                                     ===========
         Diluted                                            $         0.81                                     $      0.89
                                                             =============                                     ===========


See  accompanying  notes to unaudited  pro forma  condensed  combined  financial statements.

</TABLE>


<PAGE> 17


Notes to Unaudited Pro Forma Condensed Combined Financial Statements

On September 9, 1998,  RehabCare  acquired  TSL, a provider of contract  therapy
services to long-term care facilities and school  districts.  The aggregate cash
purchase cost, excluding acquisition costs, totaled $8.3 million,  consisting of
$5.4 million in cash, a subordinated  promissory note in the original  principal
amount of $1 million and an aggregate of 117,895 shares of common stock equal in
value  to $1.9  million.  Goodwill  recognized  as a result  of the  acquisition
totaled approximately $7.3 million.

The unaudited pro forma condensed combined balance sheet as of June 30, 1998 has
been  prepared  assuming  that the  acquisition  had  occurred  as of that date.
Unaudited pro forma condensed combined statements of earnings for the six months
ended June 30, 1998,  and the year ended December 31, 1997 have been prepared as
if the acquisition had been effected on the first day of the periods  presented.
The  unaudited  pro forma  condensed  combined  statements  of earnings  are not
necessarily  indicative of results that would have occurred had the  acquisition
been  consummated as of the beginning of the periods  presented or that might be
attained in the future.  Pro forma  adjustments  reflected in the  unaudited pro
forma condensed combined financial statements are as follows:

     1. To record the cash  consideration  of $5.4 million,  to record cash paid
for working  capital in excess of the target minimum of $1.3 million,  to record
the  issuance of  subordinated  promissory  note in the  principal  amount of $1
million, to record an aggregate of 117,895 shares of common stock equal in value
to $1.9 million, and accrue for estimated acquisition costs totaling $300,000.

     2. To eliminate the historical amounts of stockholder's equity of TSL.

     3. To reflect the  goodwill  associated  with  allocation  of the  purchase
price. Goodwill will be amortized using the straight-line method over 40 years.

     4. To  reflect  the  interest  expense  related to  incremental  borrowings
necessary to fund the cash  purchase  price and the  issuance of a  subordinated
promissory note. The interest rate on bank borrowings is assumed to be 7.00% and
7.40% for the six month period  ended June 30, 1998 and the year ended  December
31, 1997, respectively. The interest rate on the subordinated promissory note is
8%.

     5. To reflect income taxes at an estimated  combined  effective tax rate of
40%.

     6. To  reflect  reductions  associated  with  receipt  by TSL of  notice of
cancellation  of contracts  from a customer  representing  approximately  46% of
TSL's 1998 revenues.

     7. To  reflect post-acquisition  salary  adjustments  and additional  costs
associated with conforming benefit plans.


<PAGE> 18
                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Dated: November 6, 1998

                            REHABCARE GROUP, INC.



                            By:/s/ John R. Finkenkeller
                               -------------------------------------------------
                               John R. Finkenkeller
                               Senior Vice President and Chief Financial Officer





<PAGE> 19



               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS


We consent to the  incorporation  by  reference in the  Registration  Statements
(Form S-8, No. 333-11311; Form S-8, No. 33-82106; and, Form S-8, No. 33-82048)of
RehabCare  Group,  Inc. of our report  dated May 15,  1998,  with respect to the
audited  financial  statements  of  Therapeutic  Systems,  Ltd.  included in the
Current Report on Form 8-K/A of RehabCare Group, Inc. dated September 9, 1998

                                                    /s/ Mowery & Schoenfeld, LLC

November 6, 1998 








© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission